Working… Menu

CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03152708
Recruitment Status : Unknown
Verified September 2017 by CANbridge Life Sciences Ltd..
Recruitment status was:  Not yet recruiting
First Posted : May 15, 2017
Last Update Posted : September 21, 2017
Information provided by (Responsible Party):
CANbridge Life Sciences Ltd.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 1, 2017
Estimated Study Completion Date : December 31, 2017